OSA
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Prevail TherapeuticsOrforglipron
ResMedCPAP
ResMedNasal mask
Clinical Trials (3)
Total enrollment: 1,132 patients across 3 trials
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Start: Oct 2024Est. completion: Jul 2026712 patients
Phase 3Completed
Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients
Start: Jul 2022Est. completion: Oct 2026400 patients
N/AUnknown
Nasal Pillows vs. Nasal Masks at High CPAP Pressure
Start: Aug 2011Est. completion: Dec 201220 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.